Proteinuria and the risk of developing end-stage renal disease

Kidney International

Volumn 63, Issue 4, 2003, Pages 1468-1474

  Iseki, Kunitoshi ^a,b   Ikemiya, Yoshiharu ^a   Iseki, Chiho ^a   Takishita, Shuichi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

End stage renal disease; Hematuria; Proteinuria; Screening

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH SURVEY; HEMATURIA; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; URINALYSIS;

EID: 0037378449     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00868.x     Document Type: Article

References (25)

1. NAKAI S, SHINZATO T, SANAKA T, et al: An overview of regular dialysis treatment in Japan (as of Dec. 31, 1999). J Jpn Soc Dial Ther 34:1121-1147, 2001
2. SCHENA FP: Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney Int 57(Suppl 74):S39-S45, 2000
3. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
4. MASCHIO G, ALBERTI D, JANIN G, et al: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
5. BRENNER BM, COOPER ME, DEZEEUW D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
6. JUNGERS P, MASSY ZA, NGUYEN-KHOA T, et al: Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 16:2357-2364, 2001
7. ISEKI K, FOR THE OKINAWA DIALYSIS STUDY (OKIDS) GROUP: Analysis of referral pattern and survival in chronic dialysis patients in Okinawa, Japan (1993-1997). Clin Exp Nephrol 6:43-48, 2002
8. USAMI T, KOYAMA K, TAKEUCHI O, et al: Regional variation in the incidence of end-stage renal failure in Japan. JAMA 284:2622-2624, 2000
9. ISEKE K, KAWAZOE N, OSAWA A, et al: Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 43:404-409, 1993
10. ISEKI K, TOZAWA M, ISEKI C, et al: Demographic trends in Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int 61:668-675, 2002
11. ISEKI K, ISEKI C, IKEMIYA Y, et al: Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49:800-805, 1996
12. ISEKI K, IKEMIYA Y, FUKIYAMA K: Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 51:850-854, 1997
13. ISEKI K, KAWAZOE N, FUKIYAMA K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
14. ISEKI K, FUKIYAMA K: Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:1672-1675, 1996
15. ISEKI K, MIYASATO F, TOKUYAMA K, et al: Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51:1212-1217, 1997
16. SUNAGAWA H, ISEKI K, NISHIME K, et al: Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 74:361-366, 1996
17. ISEKI K, MIYASATO F, OURA T, et al: An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23:547-554, 1994
18. CULLETON BF, LARSON MG, PARFREY PS, et al: Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study. Am J Med 109:1-8, 2000
19. GRIMM RH JR, SVENDSEN KH, KASISKE B, et al: Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 52 (Suppl 63):S10-S14, 1997
20. KANNEL WB, STAMPFER MJ, CASTELLI WP, VERTER J: The prognostic significance of proteinuria. The Framingham Study. Am Heart J 108:1347-1352, 1984
21. METCALF P, BARKER J, SCOTT A, et al: Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem 38:1802-1808, 1992
22. RIBSTEIN J, DU CAILAR G, MIMRAN A: Combined renal effects of overweight and hypertension. Hypertension 26:610-615, 1995
23. HALIMI JM, GIRAUDEAU B, VOL S, et al: Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 58:1285-1292, 2000
24. HORNER D, FLISER D, KLIMM HP, RITZ E: Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 14:655-660, 1996
25. ROBINSON RR: Isolated proteinuria in asymptomatic patients. Kidney Int 18:395-406, 1980